Real-world evidence is becoming a core proof standard for MedTech manufacturers.
In this issue, Khalil Thomas explains why raw data is not enough, and why regulators, payers, and quality systems increasingly expect evidence that proves how products perform in actual use.
Khalil Thomas is a Health Equity expert and President of TRCG, a boutique Digital Health consulting group that leverages regulatory compliance expertise to bring solutions to market, manage algorithm bias, and improve quality for an expanded patient demographic. He specializes in topics at the intersection of AI, Health Tech, and Health Equity; highlighting pathways for innovation enabled equity.
